Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AER guide

This article was originally published in The Tan Sheet

Executive Summary

The Institute for Health Research is publishing an Adverse Events Reporting guide for marketers of natural products and dietary supplements who use neutral third-party AE screening companies in order to meet the standards suggested by FDA's draft AER guidance, the institute announces Oct. 13. Available online at AER-Consulting.com, the guide will also be "invaluable in the future to determine drug and non-pharmaceutical interactions," the NGO adds. FDA's Center for Food Safety and Applied Nutrition posted the draft guidance on its Web site Oct. 11; the law goes into effect Dec. 22 (1"The Tan Sheet" Oct. 15, 2007, p. 4)...

You may also be interested in...



Supplement AER Draft Guidance Omits Answers, But Recognizes Complexities

FDA's draft guidance for dietary supplement adverse event reports encourages firms to employ health care professionals to take information from consumers and other sources of adverse event calls

Health And Wellness Trademark Review 14 January, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention

Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.

Topics

UsernamePublicRestriction

Register

PS101012

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel